62 results
8-K
EX-1.1
PROK
ProKidney Corp - Ordinary Shares
13 Jun 24
ProKidney Announces Pricing of its Upsized $130 Million Public Offering of Class A Ordinary Shares and Concurrent Registered Direct Offering
9:06am
that Section 4, Section 7, Section 9 and Section 10 shall at all times be effective and shall survive such termination.
Section 7. Reimbursement of Underwriters
8-K
EX-99.2
PROK
ProKidney Corp - Ordinary Shares
10 Jun 24
ProKidney Announces Positive Interim REGEN-007 Phase 2 Trial Data and Provides Clinical and Operational Updates
8:00am
in risk prediction who developed the most widely used First autonomous AI FDA clearance and SaMD reimbursement including algorithms in nephrology … and participating FDA discussions on drug approval and Strategic advisor to Top 20 Biopharma, regulatory & reimbursement firms, labeling and venture
8-K
EX-10.1
PROK
ProKidney Corp - Ordinary Shares
25 Mar 24
ProKidney Announces Key Leadership Appointments Strengthening Clinical and Technical Operations
4:07pm
of termination and (iii) any unreimbursed business expenses in accordance with the Company’s reimbursement policy, not later than thirty (30) business … -month anniversary of such termination date and (b) the date of your death.
With respect to any reimbursements under this Agreement, such reimbursement
8-K/A
EX-10.1
7jwbc kwc9dj9p
18 Mar 24
Departure of Directors or Certain Officers
4:09pm
8-K/A
EX-10.2
xnxcppd6es bnl682
18 Mar 24
Departure of Directors or Certain Officers
4:05pm
8-K
jfgmxo6 njzywxvr
19 Jan 24
Entry into a Material Definitive Agreement
4:19pm
424B5
acuwxu828z1u2d87q xd
19 Jan 24
Prospectus supplement for primary offering
4:16pm
8-K/A
EX-10.1
4ovrdyy196q8dt
5 Dec 23
Departure of Directors or Certain Officers
4:06pm
S-3
EX-4.1
b1een
22 Nov 23
Shelf registration
9:22am
S-3
EX-4.2
wqvfr
22 Nov 23
Shelf registration
9:22am
8-K
EX-99.1
w0lzmlyb8f
11 Sep 23
Regulation FD Disclosure
8:01am
DEF 14A
2ac d01pe33ist
26 May 23
Definitive proxy
8:00am
424B3
3xoe27fnpx px
21 Apr 23
Prospectus supplement
4:18pm
POS AM
i6raqjzx2
17 Apr 23
Prospectus update (post-effective amendment)
5:01pm
424B3
i5uinp4k84bszd23sg
9 Sep 22
Prospectus supplement
5:05pm